Last $47.65 USD
Change Today -0.56 / -1.16%
Volume 474.7K
CNMD On Other Exchanges
Symbol
Exchange
Berlin
NASDAQ GS
As of 8:10 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

conmed corp (CNMD) Snapshot

Open
$48.20
Previous Close
$48.21
Day High
$48.88
Day Low
$47.15
52 Week High
02/19/14 - $49.10
52 Week Low
06/24/13 - $29.95
Market Cap
1.3B
Average Volume 10 Days
314.8K
EPS TTM
--
Shares Outstanding
27.2M
EX-Date
03/13/14
P/E TM
--
Dividend
$0.80
Dividend Yield
1.47%
Current Stock Chart for CONMED CORP (CNMD)

conmed corp (CNMD) Related Bloomberg News

View More Bloomberg News

conmed corp (CNMD) Related Businessweek News

No Related Businessweek News Found

conmed corp (CNMD) Details

CONMED Corporation provides surgical devices and equipment for minimally invasive procedures and monitoring. It offers sports medicine products, including powered resection instruments, arthroscopes, reconstructive systems, tissue repair sets, metal and bioabsorbable implants, and related disposable products and fluid management systems; powered surgical instruments for use in large and small bone orthopedic, arthroscopic, oral/maxillofacial, podiatric, plastic, ENT, neurological, spinal, and cardiothoracic surgeries; electrosurgical generators and related instruments; and 2D and 3D video systems for use in minimally invasive orthopedic and general surgeries. The company also provides patient monitoring products comprising vital signs and cardiac monitoring products, including pulse oximetry equipment and sensors, ECG electrodes and cables, cardiac defibrillation and pacing pads, and blood pressure cuffs; surgical suction instruments and tubing products; and IV products used in critical care areas. In addition, it offers endomechanical instrumentation products, such as trocars, clip appliers, scissors, and surgical staplers used in the minimally invasive laparoscopic and gynecological surgery. Further, the company provides gastrointestinal and pulmonary products consisting of minimally invasive diagnostic and therapeutic products, including mucosal management devices, forceps, scope management accessories, bronchoscopy devices, dilatation, stricture management devices, hemostasis, biliary devices, and polypectomy. Its products are used by surgeons and physicians in orthopedics, general surgery, gynecology, neurosurgery, and gastroenterology. The company operates in the United States, Canada, the United Kingdom, Japan, Australia, and internationally. CONMED Corporation was founded in 1970 and is headquartered in Utica, New York.

3,600 Employees
Last Reported Date: 02/24/14
Founded in 1970

conmed corp (CNMD) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $764.2K
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $311.5K
Executive Vice President of Corporate Commerc...
Total Annual Compensation: $361.1K
Principal accounting Officer, Executive Vice ...
Total Annual Compensation: $307.5K
General Counsel and Executive Vice President ...
Total Annual Compensation: $280.1K
Compensation as of Fiscal Year 2012.

conmed corp (CNMD) Key Developments

CONMED Reportedly Mulls Sale

CONMED Corporation (NasdaqGS:CNMD) is exploring a sale and has contacted large medical device companies to gauge their buyout interest, according to people familiar with the matter. ConMed has reportedly asked Bank of America Merrill Lynch and Greenhill & Co Inc. to approach larger orthopedic device makers regarding a potential sale of the company. Shares of ConMed were up 6.3% at $44.89 on April 15, 2014.

CONMED Mulls Acquisitions

CONMED Corporation (NasdaqGS:CNMD) is looking for acquisitions. Joseph Corasanti, President and Chief Executive Officer of Conmed Corporation said, “we are looking for acquisitions that can be tucked into the existing six business product line categories that we have".

Bonutti Skeletal Innovations LLC Enters into Settlement and Patent License Agreement with ConMed Corporation and Linvatec Corporation

Acacia Research Corporation announced that its Bonutti Skeletal Innovations LLC subsidiary has entered into a settlement and patent license agreement with ConMed Corporation and Linvatec Corporation. The agreement resolves litigation that was pending in the United States District Court for the Middle District of Florida.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
CNMD:US $47.65 USD -0.56

CNMD Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Ascom Holding AG SFr.16.55 CHF +0.10
Cantel Medical Corp $34.02 USD +0.35
Integra LifeSciences Holdings Corp $45.30 USD -0.22
Masimo Corp $26.59 USD +0.25
NuVasive Inc $33.83 USD +0.40
View Industry Companies
 

Industry Analysis

CNMD

Industry Average

Valuation CNMD Industry Range
Price/Earnings 37.7x
Price/Sales 1.8x
Price/Book 2.2x
Price/Cash Flow 36.5x
TEV/Sales 1.4x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact CONMED CORP, please visit www.conmed.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.